| Recruiting | 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT Parathyroid Adenoma | Phase 2 / Phase 3 | 2023-09-27 |
| Completed | Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prosta Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma | Phase 2 | 2020-12-15 |
| Terminated | HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer Prostate Cancer | Phase 2 | 2020-02-05 |
| Completed | 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy Prostate Cancer | Phase 1 / Phase 2 | 2019-04-09 |
| Completed | 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer Breast Carcinoma, Estrogen Receptor Positive | Phase 1 / Phase 2 | 2019-03-19 |
| Completed | 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules Cigarette Smoker, Current Smoker, Former Smoker | Phase 2 | 2019-02-04 |
| Completed | 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer Prostate Cancer | Phase 2 | 2019-01-14 |
| Completed | Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Squamous Cell Carcinoma of the Head and Neck, Carcinoma of the Head and Neck | Phase 1 | 2019-01-07 |
| Completed | 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment Prostate Adenocarcinoma, PSA Failure, Recurrent Prostate Carcinoma | Phase 2 / Phase 3 | 2017-05-20 |
| Completed | 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma, Stage IV Prostate Adenocarcinoma | Phase 2 | 2017-04-10 |
| Completed | 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing S Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma | Phase 2 / Phase 3 | 2016-04-18 |
| Completed | 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer Prostate Adenocarcinoma | Phase 2 / Phase 3 | 2015-11-16 |
| Completed | 18F-FSPG PET/CT for Cancer Patients on Therapy B-Cell Neoplasm, Estrogen Receptor Negative, HER2/Neu Negative | Phase 2 | 2015-07-01 |
| No Longer Available | 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors Carcinoid Tumors, Islet Cell (Pancreatic NET), Other Neuroendocrine Tumors | — | — |
| No Longer Available | F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two | — | — |